Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial

external-publication
infectious-diseases
antimicrobial-resistance
Authors

Garey KW

McPherson J

Dinh AQ

Hu C

Jo J

Wang W

Lancaster CK

Gonzales-Luna AJ

Loveall C

Begum K

Jahangir Alam M

Silverman MH

Hanson BM

Doi